Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 72–73 (2006)Cite this article

boxed-textMuto Y et al. (2005) Effects of branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin J Gastroenterol 3: 705–713

Branched-chain amino-acid granules are useful for the treatment of cirrhosis and chronic hepatic encephalopathy in patients who are intolerant to a standard diet and unresponsive or intolerant of lactulose

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Nakaya Y et al. (2002) Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acid-enriched nutrient mixture.[comment]. J Gastroenterol 37: 531–536

    Article  CAS  Google Scholar 

  2. Watanabe A et al. (1983) Effect of a branched chain amino acid-enriched nutritional product on the pathophysiology of the liver and nutritional state of patients with liver cirrhosis. Acta Med Okayama 37: 321–333

    CAS  PubMed  Google Scholar 

  3. Plauth M et al. (1993) Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. J Hepatol 17: 308–314

    Article  CAS  Google Scholar 

  4. Marchesini G et al. (1990) Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol 11: 92–101

    Article  CAS  Google Scholar 

  5. Egberts EH et al. (1985) Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study. Gastroenterology 88: 887–895

    Article  CAS  Google Scholar 

  6. Marchesini G et al. (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.[see comment]. Gastroenterology 124: 1792–1801

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor of Medicine at the Mayo Clinic and Foundation, Rochester, MN, USA

    Michael Charlton

Authors
  1. Michael Charlton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Charlton.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Charlton, M. Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?. Nat Rev Gastroenterol Hepatol 3, 72–73 (2006). https://doi.org/10.1038/ncpgasthep0392

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0392

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing